“…and oral exposure to the toxin induces apoptosis of hematopoietic and lymphoid tissues, including bone marrow, Peyer's patches, spleen, and thymus (Ihara et al, 1997;Shinozuka et al, 1997aShinozuka et al, , 1997bIslam et al, 1998;Nagata et al, 2001). Experimental animals similarly treated with T-2 are Toxicology and Applied Pharmacology 214 (2006) 318 -325 www.elsevier.com/locate/ytaap more susceptible to systemic infections by Salmonella Typhimurium (Tai and Pestka, 1990;Ziprin and Elissalde, 1990;Kubena et al, 2001), Listeria monocytogenes (Ziprin and McMurray, 1988;Ziprin et al, 1987), Babesia microti (Corrier and Wagner, 1988), Mycobacterium (Kanai and Kondo, 1984;Ziprin and McMurray, 1988), and Herpes simplex virus (Friend et al, 1983). Although the intestine is a principal target in ATA, little is known of T-2′s capacity to suppress the gut mucosal immune response.…”